An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain.

• Status: Completed
• Trial end date: 2014-10-01

Summary

The purpose of this study is to compare the analgesic efficacy of Xartemis 15mg/650mg by mouth every 12 hours for the management of acute moderate to severe post operative pain to generic Oxycodone/APAP(acetaminophen) (Percocet) 10mg/650mg by mouth every 6 hours.

• Phase: Phase 4

Details

• Lead Sponsor: Lotus Clinical Research, LLC
• Collaborator: Mallinckrodt
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; Analgesics; Oxycodone